1. Home
  2. AVXL vs ARL Comparison

AVXL vs ARL Comparison

Compare AVXL & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$1.51

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

SELL

Current Price

$18.00

Market Cap

256.7M

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
AVXL
ARL
Founded
2004
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
237.2M
256.7M
IPO Year
2013
1999

Fundamental Metrics

Financial Performance
Metric
AVXL
ARL
Price
$1.51
$18.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.1M
3.6K
Earning Date
11-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 206.59
EPS
★ N/A
N/A
Revenue
N/A
★ $50,014,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 5.70
52 Week Low
$1.44
$12.42
52 Week High
$9.50
$24.44

Technical Indicators

Market Signals
Indicator
AVXL
ARL
Relative Strength Index (RSI) 20.06 51.29
Support Level N/A $15.83
Resistance Level $2.80 $16.49
Average True Range (ATR) 0.13 0.85
MACD -0.03 0.13
Stochastic Oscillator 6.06 35.57

Price Performance

Historical Comparison
AVXL
ARL

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments: the acquisition, development, ownership and management of multifamily properties (Residential Segment) and the acquisition, ownership and management of commercial real estate properties (Commercial Segment). Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: